import Image1 from "../images/Image-1.jpg";
import Image2 from "../images/Image-2.jpg";
import Image3 from "../images/Image-3.jpg";
import Image4 from "../images/Image-4.jpg";
import Image5 from "../images/Image-5.jpg";
import Image6 from "../images/Image-6.jpg";
import Image7 from "../images/Image-7.jpg";
import Image8 from "../images/Image-8.jpg";

const newsData = [
    {
        country: "United States of America",
        heading: "New omicron boosters are now available at U.S.",
        description:
            "The U.S. authorized the first major makeover of the Covid-19 vaccines this week in an effort to stem an expected tide of infections and hospitalizations this fall.",
        author: "William Raff",
        date: "Sep, 06, 2022",
        timeInMins: "4",
        image: Image1,
        imageAlt: "An ilustration of the Coronavirus",
    },
    {
        country: "China",
        heading: "China approves first inhaled Covid vaccine",
        description:
            "China has become the first country to green-light an inhaled Covid-19 vaccine, paving the way for potential use of the needle-free product in the country, where suppressing the spread of Covid-19 remains a top priority.",
        author: "Rose Hutchinson",
        date: "Sep, 06, 2022",
        timeInMins: "8",
        image: Image2,
        imageAlt: "A group of Covid-19 vaccines",
    },
    {
        country: "Canada",
        heading:
            "What protection to expect from updated COVID vaccines this fall",
        description:
            "An updated Moderna vaccine is expected to roll out in Canada within days, and researchers will be watching how much added protection it offers.",
        author: "Adam Miller",
        date: "Sep, 05, 2022",
        timeInMins: "6",
        image: Image3,
        imageAlt: "Biosecurity elements for covid-19",
    },
    {
        country: "United Kingdom",
        heading:
            "First bivalent COVID-19 booster vaccine approved by UK medicines regulator",
        description:
            "The adapted COVID-19 vaccine made by Moderna targets two different coronavirus variants: the original virus from 2020 and the Omicron variant.",
        author: "Larry Parker",
        date: "Sep, 04, 2022",
        timeInMins: "12",
        image: Image4,
        imageAlt: "A doctor getting ready for her shift",
    },
    {
        country: "Switzerland",
        heading: "Interim statement on COVID-19 vaccination for children",
        description:
            "WHO is currently reviewing the emerging evidence on the need for and timing of vaccinating children and adolescents with the currently available COVID-19 vaccines, which have received Emergency Use Listing (EUL).",
        author: "World Health Organization",
        date: "Sep, 03, 2022",
        timeInMins: "16",
        image: Image5,
        imageAlt: "A child wearing a mask",
    },
    {
        country: "United States of America",
        heading:
            "Biden administration is preparing for the end of free COVID-19",
        description:
            "The federal budget for buying and distributing COVID-19 vaccines will run out as early as January.",
        author: "Lucy Vargas",
        date: "Sep, 03, 2022",
        timeInMins: "7",
        image: Image6,
        imageAlt: "A nurse giving an injection",
    },
    {
        country: "Spain",
        heading: "COVID-19 vaccine campaigns could be faster, industry says",
        description:
            "Speed is of the essence to protect citizens from new COVID-19 outbreaks this fall, but the process to distribute more vaccines must be accelerated, according to pharmaceutical industry representatives.",
        author: "Isabel Silva",
        date: "Sep, 02, 2022",
        timeInMins: "4",
        image: Image7,
        imageAlt: "A young girl washing her hands",
    },
    {
        country: "Israel",
        heading:
            "Data from Israel: myocarditis after COVID-19 vaccines remain rare",
        description:
            "A new study from Israel found that the risk of developing myocarditis among males ages 16 to 19 years was about 1 in 15,000 after third dose of the Pfizer COVID-19 vaccine",
        author: "John Davis",
        date: "Sep, 06, 2022",
        timeInMins: "22",
        image: Image8,
        imageAlt: "A man wearing a mask. The man is a little worried",
    },
];

export default newsData;
